NASDAQ:SNSS - Sunesis Pharmaceuticals SEC Filings & 10K Form

$0.91
+0.06 (+7.06 %)
(As of 07/17/2019 04:00 PM ET)
Today's Range
$0.84
Now: $0.91
$0.93
50-Day Range
$0.57
MA: $0.74
$0.98
52-Week Range
$0.20
Now: $0.91
$2.60
Volume64,256 shs
Average Volume1.40 million shs
Market Capitalization$66.00 million
P/E RatioN/A
Dividend YieldN/A
Beta2.75

SEC Filings

Sunesis Pharmaceuticals (NASDAQ:SNSS) SEC Filings

DateFilerForm TypeView
07/15/2019
3:15 PM
Aisling Capital IV, LP (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
07/15/2019
3:15 PM
Aisling Capital IV, LP (Reporting)
Aisling Capital Partners IV LLC (Reporting)
Aisling Capital Partners IV, LP (Reporting)
ELMS STEVE (Reporting)
SCHIFF ANDREW N (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/12/2019
5:15 AM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
07/12/2019
5:12 AM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
07/11/2019
7:12 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2019
3:22 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
07/10/2019
3:21 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
07/10/2019
3:05 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/09/2019
3:49 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/02/2019
4:31 PM
Misfeldt Dayton (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
4:28 PM
Sunesis Pharmaceuticals (Issuer)
YOUNG JAMES W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
4:24 PM
Carchedi Steve (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
4:23 PM
Ketchum Steven B (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
4:21 PM
STUMP DAVID C (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
4:21 PM
Sunesis Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
4:19 PM
Pearce Homer L (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/06/2019
3:13 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2019
4:13 PM
Sunesis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
05/08/2019
3:55 PM
Sunesis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/08/2019
3:12 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/29/2019
3:12 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/12/2019
4:30 PM
Sunesis Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/12/2019
4:30 PM
Sunesis Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/01/2019
3:14 PM
Quinn William P. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/01/2019
3:13 PM
Fox Judith A. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/25/2019
8:13 PM
Fox Judith A. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/18/2019
9:05 AM
Sunesis Pharmaceuticals (Filer)
Form CT ORDER
View Filing
03/18/2019
8:51 AM
Sunesis Pharmaceuticals (Filer)
Form CT ORDER
View Filing
03/07/2019
4:00 PM
Sunesis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/07/2019
3:12 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/04/2019
2:08 PM
Quinn William P. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
3:56 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2019
11:16 AM
BALYASNY ASSET MANAGEMENT LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/04/2019
4:08 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/28/2019
4:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G
View Filing
01/25/2019
10:52 AM
JFL Capital Management, LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G
View Filing
01/24/2019
4:23 PM
Aisling Capital IV, LP (Reporting)
Aisling Capital Partners IV LLC (Reporting)
Aisling Capital Partners IV, LP (Reporting)
ELMS STEVE (Reporting)
SCHIFF ANDREW N (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/24/2019
4:21 PM
Aisling Capital IV, LP (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
01/18/2019
7:47 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
01/18/2019
7:40 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
01/18/2019
7:35 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/17/2019
3:19 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
01/17/2019
3:16 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
01/11/2019
4:25 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
8:00 AM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2019
6:16 PM
Quinn William P. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2019
6:15 PM
Misfeldt Dayton (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/12/2018
3:57 PM
Quinn William P. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/03/2018
1:10 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/05/2018
3:44 PM
Sunesis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/05/2018
3:14 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/07/2018
6:17 PM
Sunesis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/10/2018
3:30 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
07/03/2018
7:03 PM
Pearce Homer L (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
7:01 PM
STUMP DAVID C (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
6:58 PM
Ketchum Steven B (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
6:52 PM
Carchedi Steve (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
6:47 PM
Sunesis Pharmaceuticals (Issuer)
YOUNG JAMES W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
6:39 PM
Misfeldt Dayton (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
6:33 PM
Sunesis Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
6:31 PM
Sunesis Pharmaceuticals (Issuer)
Wolff Henry Ward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/26/2018
4:01 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/25/2018
3:09 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/25/2018
3:07 PM
Sunesis Pharmaceuticals (Filer)
Form 424B5
View Filing
06/07/2018
5:01 AM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/25/2018
12:38 PM
Sunesis Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/25/2018
12:20 PM
Sunesis Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/12/2018
4:06 PM
Sunesis Pharmaceuticals (Filer)
Form PRE 14A
View Filing
03/13/2018
4:07 PM
Sunesis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/09/2018
3:58 PM
Sunesis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/08/2018
3:12 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/05/2018
4:15 PM
Boxer Capital, LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G
View Filing
02/14/2018
3:54 PM
GREAT POINT PARTNERS LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2018
1:51 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2018
11:01 AM
BALYASNY ASSET MANAGEMENT LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/12/2018
4:17 PM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Sunesis Pharmaceuticals (Subject)
Form SC 13G
View Filing
02/06/2018
3:06 PM
Sunesis Pharmaceuticals (Subject)
UBS Oncology Impact Fund L.P. (Filed by)
Form SC 13G/A
View Filing
02/05/2018
3:30 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2018
3:10 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/02/2018
7:11 PM
Misfeldt Dayton (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/15/2017
4:08 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/04/2017
5:00 PM
Quinn William P. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/04/2017
4:46 PM
Quinn William P. (Reporting)
Sunesis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/04/2017
3:45 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/30/2017
3:06 PM
Sunesis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 7/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel